AAAAAA

   
Results: 1-19 |
Results: 19
SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP
Authors: GULICK RM MELLORS JW HAVLIR D ERON JJ GONZALEZ C MCMAHON D JONAS L MEIBOHM A HOLDER D SCHLEIF WA CONDRA JH EMINI EA ISAACS R CHODAKEWITZ JA RICHMAN DD
Citation: Rm. Gulick et al., SIMULTANEOUS VS SEQUENTIAL INITIATION OF THERAPY WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE FOR HIV-1 INFECTION - 100-WEEK FOLLOW-UP, JAMA, the journal of the American Medical Association, 280(1), 1998, pp. 35-41
ABERRANT AND UNSTABLE EXPRESSION OF IMMUNOGLOBULIN GENES IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: BESSUDO A RASSENTI L HAVLIR D RICHMAN D FEIGAL E KIPPS TJ
Citation: A. Bessudo et al., ABERRANT AND UNSTABLE EXPRESSION OF IMMUNOGLOBULIN GENES IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Blood, 92(4), 1998, pp. 1317-1323
SKEWED AND UNSTABLE B-CELL REPERTOIRE IN SERIAL BLOOD-SAMPLES OF HIV-INFECTED PATIENTS, POTENTIAL ROLE IN THE INDUCTION OF AIDS-ASSOCIATED LYMPHOMA
Authors: BESSUDO A RASSENTI L RICHMAN D HAVLIR D FEIGAL E KIPPS TJ
Citation: A. Bessudo et al., SKEWED AND UNSTABLE B-CELL REPERTOIRE IN SERIAL BLOOD-SAMPLES OF HIV-INFECTED PATIENTS, POTENTIAL ROLE IN THE INDUCTION OF AIDS-ASSOCIATED LYMPHOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 138-138
PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/
Authors: MASUR H KAPLAN JE HOLMES KK BAKER AC BARR D BENSON C BROSGART C CHAISSON R COOPER E CRUMPACKER C DECKER C DREW L EISINGER R ELSADR W FREEDBERG K GOLDBERGER M GORDIN F GREAVES W GROSS P HAFNER R HAVLIR D HORSBURGH R JABS D KITAHATA M KOVACS J MARTONE W MAYERS D MELNICK D MOFENSON L NEATON J NELSON C OLDFIELD E PHAIR J POLIS M POLSKY B POWDERLY W RIMLAND D SLOAND E SOLOMON L SPECTOR S SPERLING R TRAPNELL CB VANDYKE R WHITLEY R WRIGHT T BELAY E BUTLER JC CASTRO KG DYKEWICZ C EDLIN BR ELLERBROCK T HAJJEH RA JAFFE HW JURANEK D MCNEIL M MILLER B PELLETT PE REEVES W SCHLUTER WW SPIEGEL RA STEWART JA STYRT B VERNON SD WARD J
Citation: H. Masur et al., PREFACE TO THE 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Clinical infectious diseases, 25, 1997, pp. 299
1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/
Authors: MASUR H KAPLAN JE HOLMES KK ARMSTRONG D BAKER AC BARR D BENSON C BROSGART C CHAISSON R COOPER E CRUMPACKER C DECKER C DREW L EISINGER R ELSADR W FREEDBERG K GOLDBERGER M GORDIN F GREAVES W GROSS P HAFNER R HAVLIR D HORSBURGH R JABS D KITAHATA M KOVACS J MARTONE W MAYERS D MELNICK D MOFENSON L NEATON J NELSON C OLDFIELD E PHAIR J POLIS M POLSKY B POWDERLY W RIMLAND D SLOAND E SOLOMON L SPECTOR S SPERLING R TRAPNELL CB VANDYKE R WHITLEY R WRIGHT T BELAY E BUTLER JC CASTRO KG DYKEWICZ C EDLIN BR ELLERBROCK T HAJJEH RA JAFFE HW JURANEK D MCNEIL M MILLER B PELLETT PE REEVES W SCHLUTER WW SPIEGEL RA STEWART JA STYRT B VERNON SD WARD J
Citation: H. Masur et al., 1997 USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/, Clinical infectious diseases, 25, 1997, pp. 313-335
TREATMENT WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE IN ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND PRIOR ANTIRETROVIRAL THERAPY
Authors: GULICK RM MELLORS JW HAVLIR D ERON JJ GONZALEZ C MCMAHON D RICHMAN DD VALENTINE FT JONAS L MEIBOHM A EMINI EA CHODAKEWITZ JA
Citation: Rm. Gulick et al., TREATMENT WITH INDINAVIR, ZIDOVUDINE, AND LAMIVUDINE IN ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND PRIOR ANTIRETROVIRAL THERAPY, The New England journal of medicine, 337(11), 1997, pp. 734-739
IN-VIVO COMPARTMENTALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS - EVIDENCE FROM THE EXAMINATION OF POL SEQUENCES FROM AUTOPSY TISSUES
Authors: WONG JK IGNACIO CC TORRIANI F HAVLIR D FITCH NJS RICHMAN DD
Citation: Jk. Wong et al., IN-VIVO COMPARTMENTALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS - EVIDENCE FROM THE EXAMINATION OF POL SEQUENCES FROM AUTOPSY TISSUES, Journal of virology, 71(3), 1997, pp. 2059-2071
NEVIRAPINE - A VIEWPOINT
Authors: HAVLIR D
Citation: D. Havlir, NEVIRAPINE - A VIEWPOINT, CLINICAL IMMUNOTHERAPEUTICS, 6(4), 1996, pp. 318-318
KINETIC-ANALYSIS OF INTRAVIRION REVERSE TRANSCRIPTION IN THE BLOOD-PLASMA OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS - DIRECT ASSESSMENT OF RESISTANCE TO REVERSE-TRANSCRIPTASE INHIBITORS IN-VIVO
Authors: ZHANG H DORNADULA G WU Y HAVLIR D RICHMAN DD POMERANTZ RJ
Citation: H. Zhang et al., KINETIC-ANALYSIS OF INTRAVIRION REVERSE TRANSCRIPTION IN THE BLOOD-PLASMA OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS - DIRECT ASSESSMENT OF RESISTANCE TO REVERSE-TRANSCRIPTASE INHIBITORS IN-VIVO, Journal of virology, 70(1), 1996, pp. 628-634
PHASE I II EVALUATION OF NEVIRAPINE ALONE AND IN COMBINATION WITH ZIDOVUDINE FOR INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS/
Authors: CHEESEMAN SH HAVLIR D MCLAUGHLIN MM GREENOUGH TC SULLIVAN JL HALL D HATTOX SE SPECTOR SA STEIN DS MYERS M RICHMAN DD
Citation: Sh. Cheeseman et al., PHASE I II EVALUATION OF NEVIRAPINE ALONE AND IN COMBINATION WITH ZIDOVUDINE FOR INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS/, Journal of acquired immune deficiency syndromes and human retrovirology, 8(2), 1995, pp. 141-151
ANTIRETROVIRAL THERAPY
Authors: HAVLIR D RICHMAN DD
Citation: D. Havlir et Dd. Richman, ANTIRETROVIRAL THERAPY, Current opinion in infectious diseases, 8(1), 1995, pp. 66-73
A PILOT-STUDY TO EVALUATE THE DEVELOPMENT OF RESISTANCE TO NEVIRAPINEIN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH CD4 CELL COUNTS OF GREATER-THAN-500 MM(3) - AIDS CLINICAL-TRIALS GROUP PROTOCOL-208/
Authors: HAVLIR D MCLAUGHLIN MM RICHMAN DD
Citation: D. Havlir et al., A PILOT-STUDY TO EVALUATE THE DEVELOPMENT OF RESISTANCE TO NEVIRAPINEIN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH CD4 CELL COUNTS OF GREATER-THAN-500 MM(3) - AIDS CLINICAL-TRIALS GROUP PROTOCOL-208/, The Journal of infectious diseases, 172(5), 1995, pp. 1379-1383
HIGH-DOSE NEVIRAPINE - SAFETY, PHARMACOKINETICS, AND ANTIVIRAL EFFECTIN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: HAVLIR D CHEESEMAN SH MCLAUGHLIN M MURPHY R ERICE A SPECTOR SA GREENOUGH TC SULLIVAN JL HALL D MYERS M LAMSON M RICHMAN DD
Citation: D. Havlir et al., HIGH-DOSE NEVIRAPINE - SAFETY, PHARMACOKINETICS, AND ANTIVIRAL EFFECTIN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 171(3), 1995, pp. 537-545
ZIDOVUDINE SHOULD BE GIVEN BEFORE HIV-POSITIVE INDIVIDUALS DEVELOP SYMPTOMS
Authors: HAVLIR D RICHMAN DD
Citation: D. Havlir et Dd. Richman, ZIDOVUDINE SHOULD BE GIVEN BEFORE HIV-POSITIVE INDIVIDUALS DEVELOP SYMPTOMS, Reviews in medical virology, 4(2), 1994, pp. 75-80
NEVIRAPINE RESISTANCE MUTATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SELECTED DURING THERAPY
Authors: RICHMAN DD HAVLIR D CORBEIL J LOONEY D IGNACIO C SPECTOR SA SULLIVAN J CHEESEMAN S BARRINGER K PAULETTI D SHIH CK MYERS M GRIFFIN J
Citation: Dd. Richman et al., NEVIRAPINE RESISTANCE MUTATIONS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SELECTED DURING THERAPY, Journal of virology, 68(3), 1994, pp. 1660-1666
TRANSIENT BACTEREMIA DUE TO MYCOBACTERIUM-AVIUM COMPLEX IN PATIENTS WITH AIDS
Authors: KEMPER CA HAVLIR D BARTOK AE KANE C CAMP B LANE N DERESINSKI SC
Citation: Ca. Kemper et al., TRANSIENT BACTEREMIA DUE TO MYCOBACTERIUM-AVIUM COMPLEX IN PATIENTS WITH AIDS, The Journal of infectious diseases, 170(2), 1994, pp. 488-493
THE INDIVIDUAL MICROBIOLOGIC EFFECT OF 3 ANTIMYCOBACTERIAL AGENTS, CLOFAZIMINE, ETHAMBUTOL, AND RIFAMPIN, ON MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN PATIENTS WITH AIDS
Authors: KEMPER CA HAVLIR D HAGHIGHAT D DUBE M BARTOK AE SISON JP YAO YZ YANGCO B LEEDOM JM TILLES JG MCCUTCHAN JA DERESINSKI SC
Citation: Ca. Kemper et al., THE INDIVIDUAL MICROBIOLOGIC EFFECT OF 3 ANTIMYCOBACTERIAL AGENTS, CLOFAZIMINE, ETHAMBUTOL, AND RIFAMPIN, ON MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN PATIENTS WITH AIDS, The Journal of infectious diseases, 170(1), 1994, pp. 157-164
UVEITIS ASSOCIATED WITH RIFABUTIN PROPHYLAXIS
Authors: HAVLIR D TORRIANI F DUBE M
Citation: D. Havlir et al., UVEITIS ASSOCIATED WITH RIFABUTIN PROPHYLAXIS, Annals of internal medicine, 121(7), 1994, pp. 510-512
REPRODUCIBILITY OF LYSIS-CENTRIFUGATION CULTURES FOR QUANTIFICATION OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA
Authors: HAVLIR D KEMPER CA DERESINSKI SC
Citation: D. Havlir et al., REPRODUCIBILITY OF LYSIS-CENTRIFUGATION CULTURES FOR QUANTIFICATION OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA, Journal of clinical microbiology, 31(7), 1993, pp. 1794-1798
Risultati: 1-19 |